Today

Agents

Chat

Arena

Discover

More

App

Vanda Pharmaceuticals target price cut to $4.50 from $5.75

VNDA•2026-10-27

Jefferies cut its target price for Vanda Pharmaceuticals to $4.50 from $5.75.

Related News

S

Smithfield Foods Q3 2026 adjusted net income drops 55% to $103 million

SFD•2026-10-27

Alert incorrectly tagged to Ancora Indonesia Resources withdrawn

FUL•2026-10-27

Oncolytics reports about 15-month median response duration for pelareorep combination in anal cancer trial

ONCY•2026-10-27

Chanson International Holding holds extraordinary general meeting

CHSN•2026-10-27

TD Cowen cuts Artiva Biotherapeutics to hold from buy

ARTV•2026-10-27

Vanda Pharmaceuticals target price cut to $4.50 from $5.75 - VNDA News | Rallies